Non-helicobacter pylori peptic ulcer in children: Pathological characteristics and complications
Main Article Content
Abstract
Non-Helicobacter pylori peptic ulcer disease (PUD) in children has been increasingly recognized, but its clinicopathological characteristics and complications have not been fully described. We conducted a study on 127 children with H. pylori-negative PUD at the Vietnam National Children’s Hospital from October 2022 to September 2024. The mean age was 10.3 ± 2.8 years, and 68.5% were male. Abdominal pain was the most common symptom (83.5%), but it often presented with non-specific features. Ulcers were predominantly located in the duodenal bulb and duodenum (89.8%), with high rates of multiple ulcers (30.7%), giant ulcers (31.5%), and deep-base ulcers (53.5%). Histopathology revealed mainly mild to moderate chronic inflammation with mild activity, and eosinophilic infiltration was observed in 27.6% of cases. The most frequent complication was anemia, with about 30% of patients requiring blood transfusion; nearly half showed duodenal deformity, and six required surgery. H. pylori-negative PUD in children demonstrates heterogeneous pathological features and a high risk of complications, warranting close monitoring and appropriate long-term management.
Article Details
Keywords
Peptic ulcer, pediatric, non-Helicobacter pylori
References
2. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017; 390(10094): 613-624. doi:10.1016/S0140-6736(16)32404-7.
3. Chung WC, Jeon EJ, Kim DB, et al. Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding. World J Gastroenterol. 2015; 21(28): 8636-8643. doi:10.3748/wjg.v21.i28.8636.
4. Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009; 30(8): 791-815. doi:10.1111/j.1365-2036.2009.04105.x.
5. Iijima K, Kanno T, Koike T, et al. Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: Negative idiopathic ulcers in Asia. World J Gastroenterol. 2014; 20(3): 706-713. doi:10.3748/wjg.v20.i3.706.
6. Chung CS, Chiang TH, Lee YC. A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers. Korean J Intern Med. 2015; 30(5): 559-570. doi:10.3904/kjim.2015.30.5.559.
7. Elitsur Y, Lawrence Z. Non-Helicobacter pylori related duodenal ulcer disease in children. Helicobacter. 2001; 6(3): 239-243. doi:10.1046/j.1523-5378.2001.00034.x.
8. Yeh PJ, Chen CC, Chao HC, et al. The trends of pediatric duodenal ulcer and predictors of recurrence. Journal of the Formosan Medical Association. 2024; 123(10): 1070-1077. doi:10.1016/j.jfma.2024.04.011.
9. Reust CE, Williams A. Recurrent Abdominal Pain in Children. afp. 2018; 97(12): 785-793.
10. Koutri E, Papadopoulou A. Eosinophilic Gastrointestinal Diseases in Childhood. Ann Nutr Metab. 2018; 73(Suppl. 4): 18-28. doi:10.1159/000493668.
11. Nguyễn Hữu Hiếu. Tình trạng kháng kháng sinh và kết quả điều trị loét dạ dày tá tràng do Helicobacter pylori theo kháng sinh đồ ở trẻ em. Luận văn Thạc sĩ y học. Trường Đại học Y Hà Nội; 2021. Accessed December 14, 2024. http://dulieuso.hmu.edu.vn/handle/hmu/2364.
12. Nguyễn Phúc Thịnh, Hoàng Lê Phúc, Nguyễn Việt Trường và cộng sự. Loét dạ dày tá tràng do H. pylori ở trẻ em tại bệnh viện Nhi Đồng 1 TP. Hồ Chí Minh. Tạp chí Y học Thành phố Hồ Chí Minh. 2014; 18(4): 41-47.
13. Vidović S, Borović S, Bašković M, et al. Perforated peptic ulcers in children: a systematic review. BMC Pediatrics. 2025; 25(1): 363. doi:10.1186/s12887-025-05725-2.
14. Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). Journal of Pediatric Gastroenterology and Nutrition. 2017; 64(6): 991-1003. doi:10.1097/MPG.0000000000001594.